InspireMD (NSPR) Net Cash Flow (2010 - 2025)

InspireMD has reported Net Cash Flow for 16 years, with the latest figure at -$54.5 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow fell 1883.31% year-over-year to -$54.5 million; the trailing twelve-month figure through Dec 2025 stood at -$10.1 million (down 16.98% YoY), and the FY2025 full-year result was -$10.1 million, down 209.42% from the prior year.
• Net Cash Flow for Q4 2025 stood at -$54.5 million, down from $51.8 million in the prior quarter.
• The five-year high for Net Cash Flow was $51.8 million in Q3 2025, with the low at -$54.5 million in Q4 2025.
• Historically, Net Cash Flow has averaged -$3.0 million across 5 years, with a median of -$1.2 million in 2021.
• Annual changes were most pronounced in 2021 — Net Cash Flow soared 1434.03% — and 2025, when it slumped 2565.59%.
• InspireMD's Net Cash Flow stood at -$1.1 million in 2021, then soared by 165.19% to $691000.0 in 2022, then plunged by 709.7% to -$4.2 million in 2023, then soared by 172.51% to $3.1 million in 2024, then sank by 1883.31% to -$54.5 million in 2025.
• The last three Net Cash Flow figures came in at -$54.5 million (Q4 2025), $51.8 million (Q3 2025), and -$874000.0 (Q2 2025), per Business Quant data.